glp 1 and binge eating disorder New hope for bulimia: GLP-1 drugs could be the key GLP-1 Agonist for Binge Eating

1 Metabolic diseases like obesity and overweight have traditionally been treated with combinations of behavioral therapy and pharmacotherapy, the latter of which was often associated with poor efficacy and weight regain after medication cessation

Glucagon-like peptide-1-based therapy is a popular treatment for type 2 diabetes

Caution: Keep out of reach of children

Visceral adiposity contributes to chronic low-grade inflammation through macrophage activation, altered T-cell responses, and adipokine imbalance ( Beyond obesity, insulin resistance and hyperinsulinemia appear to play an active role in sustaining inflammatory arthritis rather than representing mere epiphenomena of chronic inflammation

Redox Signal 20 (4), 545556

This process helps people feel fuller for longer, which reduces their appetite and can lead to weight loss